The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: ##STR00001## which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

 
Web www.patentalert.com

< HIV-1 glycopeptides and derivatives; preparation and applications thereof

< Anti-CD3 antibodies and methods of use thereof

> Method for screening for bacterial conjunctivitis

> Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B

~ 00610